MUMBAI: When it comes to healthcare software, the paperwork has often been as intensive as the programming. Tata Elxsi now wants AI to handle both.
Tata Elxsi has unveiled AnaTel, an AI-powered software engineering platform designed to help healthcare and medical technology companies build, test and document software faster while staying compliant with increasingly stringent regulations.
Developed in partnership with OpenAna, the AI-native platform made its debut at DeviceTalks Boston 2026, where Tata Elxsi showcased its latest advances in AI-driven MedTech engineering.
The launch comes as healthcare software teams face mounting pressure from evolving regulatory requirements. With authorities such as the US Food and Drug Administration (FDA) and European regulators tightening expectations around AI-enabled medical software, companies are being asked to provide more detailed documentation, stronger traceability and comprehensive validation records throughout a product’s lifecycle.
That means software development today involves far more than writing code. Every requirement, update, test and approval must be tracked, documented and ready for audit a challenge AnaTel is designed to tackle.
According to Tata Elxsi, the platform embeds autonomous AI agents directly into engineering workflows, automating tasks ranging from requirements mapping and system architecture design to coding, testing, validation and regulatory documentation. Rather than acting as a simple coding assistant, AnaTel is positioned as a full-scale engineering platform built specifically for regulated healthcare environments.
The company says the platform can reduce Software as a Medical Device (SaMD) development and change assessment timelines from nearly eight weeks to just 72 hours, while boosting engineering productivity by as much as 60 per cent.
Beyond the technology itself, AnaTel reflects a broader shift in how artificial intelligence is being adopted across industries. AI is increasingly moving beyond standalone productivity tools and becoming embedded within the operational backbone of organisations.
In healthcare, where regulatory complexity has traditionally slowed innovation, AI-native engineering platforms could help companies accelerate product development without compromising compliance, safety or audit readiness.
For Tata Elxsi, the launch also highlights an industry-wide transformation. Engineering services firms are steadily evolving into specialised AI platform providers, particularly in sectors where deep domain expertise and regulatory knowledge offer a competitive edge.
As healthcare software grows more intelligent and compliance demands continue to rise, the next wave of AI innovation may not be about smarter medical products alone but smarter ways of building them.
